公司问答丨ST诺泰：公司目前已取得磷酸奥司他韦胶囊、磷酸奥司他韦颗粒、磷酸奥司他韦干混悬剂三个剂型的药品注册证书

Core Viewpoint - ST诺泰 has obtained drug registration certificates for three formulations of Oseltamivir, indicating its involvement in the production and sale of antiviral flu medications [1] Group 1 - The company has received registration certificates for Oseltamivir capsules, granules, and dry suspension [1] - Specific sales figures for these products will be disclosed in the company's annual report [1] - Relevant announcements regarding the registration certificates can be found in previously disclosed documents [1]